TLSI Q3 2025 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$12M+57.4% YoY

Gross Profit

$10M83.5% margin

Operating Income

-$9M-77.9% margin

Net Income

-$11M-93.5% margin

EPS (Diluted)

$-0.96

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$36M

Total Liabilities

$63M

Stockholders' Equity

-$27M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$7M	+57.4%
Gross Profit	$10M	$6M	+52.2%
Operating Income	-$9M	-$9M	-3.1%
Net Income	-$11M	-$2M	-350.6%